Page last updated: 2024-12-08

6-nitro-3-phenylacetamidobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-nitro-3-phenylacetamidobenzoic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193864
SCHEMBL ID3392821
MeSH IDM0052656

Synonyms (24)

Synonym
AKOS015833314
nipab
6-nitro-3-(phenylacetamido)benzoic acid, >=98%
52033-70-2
2-nitro-5-[(phenylacetyl)amino]benzoic acid
SCHEMBL3392821
2-nitro-5-[(2-phenylacetyl)amino]benzoic acid
2-nitro-5-(phenylacetylamino)-benzoic acid
benzoic acid, 2-nitro-5-((phenylacetyl)amino)-
6-nitro-3-phenylacetamidobenzoic acid
6-nitro-3-(phenylacetamido)benzoic acid
benzoic acid,2-nitro-5-[(2-phenylacetyl)amino]-
2-nitro-5-[(phenylacetyl)amino]benzoic acid #
2-nitro-5-(2-phenylacetamido)benzoic acid
mfcd00043603
DTXSID40200007
2-nitro-5-(2-phenylacetamido)benzoicacid
SS-5222
2-nitro-5-((phenylacetyl)amino)benzoic acid
AMY28117
CS-0062160
W17028
CCA03370
SY277913
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.77 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]